These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34805284)

  • 1. Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation.
    AlAjmi MF; Khan S; Choudhury A; Mohammad T; Noor S; Hussain A; Lu W; Eapen MS; Chimankar V; Hansbro PM; Sohal SS; Elasbali AM; Hassan MI
    Front Mol Biosci; 2021; 8():780284. PubMed ID: 34805284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating single amino acid substitutions in PIM1 kinase: A structural genomics approach.
    Shafie A; Khan S; Batra S; Anjum F; Mohammad T; Alam S; Yadav DK; Islam A; Hassan MI
    PLoS One; 2021; 16(10):e0258929. PubMed ID: 34679086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of single amino acid substitution on the structure and function of TANK-binding kinase-1.
    Umair M; Khan S; Mohammad T; Shafie A; Anjum F; Islam A; Hassan MI
    J Cell Biochem; 2021 Oct; 122(10):1475-1490. PubMed ID: 34237165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies.
    Mohammad T; Siddiqui S; Shamsi A; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan MI
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
    Kobayashi T; Deak M; Morrice N; Cohen P
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational insights into the active structure of SGK1 and its implication for ligand design.
    Akhoon BA; Gandhi NS; Pandey R
    Biochimie; 2019 Oct; 165():57-66. PubMed ID: 31302161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors.
    Jang H; Park Y; Jang J
    Front Pharmacol; 2022; 13():1036844. PubMed ID: 36457711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene regulation of ENaC subunits by serum- and glucocorticoid-inducible kinase-1.
    Boyd C; Náray-Fejes-Tóth A
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F505-12. PubMed ID: 15536167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking SGK1 inhibitor potential of bis-[1-N,7-N, pyrazolo tetraethoxyphthalimido{-4-(3,5-Dimethyl-4-(spiro-3-methylpyazolo)-1,7-dihydro-1H-dipyrazolo[3,4-b;4',3'-e]pyridin-8-yl)}]p-disubstituted phenyl compounds: a computational study.
    Verma AK; Ahmed SF; Hossain MS; Bhojiya AA; Upadhyay SK; Srivastava AK; Singh N; Harina H; Rahaman MM; Bahadur NM
    J Biomol Struct Dyn; 2022; 40(24):13412-13431. PubMed ID: 34696688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients.
    Trochen N; Ganapathipillai S; Ferrari P; Frey BM; Frey FJ
    Nephrol Dial Transplant; 2004 Oct; 19(10):2499-504. PubMed ID: 15304560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinicopathological significance of glucocorticoid receptor, SGK1, and NDRG1 in hormone-naïve prostate carcinoma.
    Hata S; Shimada H; Sato N; Koshiishi M; Ise K; Ogata T; Yamashita S; Ito A; Sasano H; Nakamura Y
    Med Mol Morphol; 2022 Dec; 55(4):283-291. PubMed ID: 35861941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
    García-Martínez JM; Alessi DR
    Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NH2 terminus of serum and glucocorticoid-regulated kinase 1 binds to phosphoinositides and is essential for isoform-specific physiological functions.
    Pao AC; McCormick JA; Li H; Siu J; Govaerts C; Bhalla V; Soundararajan R; Pearce D
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1741-50. PubMed ID: 17356130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum and glucocorticoid-regulated kinase 1 in cellular signaling: Implications for drug development.
    Gulzar M; Noor S; Hasan GM; Hassan MI
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128725. PubMed ID: 38092114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms.
    Lang F; Cohen P
    Sci STKE; 2001 Nov; 2001(108):re17. PubMed ID: 11707620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star.
    Zhu R; Yang G; Cao Z; Shen K; Zheng L; Xiao J; You L; Zhang T
    Ther Adv Med Oncol; 2020; 12():1758835920940946. PubMed ID: 32728395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.
    Szmulewitz RZ; Chung E; Al-Ahmadie H; Daniel S; Kocherginsky M; Razmaria A; Zagaja GP; Brendler CB; Stadler WM; Conzen SD
    Prostate; 2012 Feb; 72(2):157-64. PubMed ID: 21563193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of 3-phosphoinositide-dependent kinase 1 (PDK1) and serum- and glucocorticoid-induced protein kinase 1 (SGK1) by short-chain sphingolipid C4-ceramide rescues the trafficking defect of ΔF508-cystic fibrosis transmembrane conductance regulator (ΔF508-CFTR).
    Caohuy H; Yang Q; Eudy Y; Ha TA; Xu AE; Glover M; Frizzell RA; Jozwik C; Pollard HB
    J Biol Chem; 2014 Dec; 289(52):35953-68. PubMed ID: 25384981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and γ-ray irradiation was elucidated.
    Tang Z; Shen Q; Xie H; Zhou Z; Shi G; Zhang C; Mohammed A; Wu Y; Ni S; Zhou X
    Oncol Rep; 2018 Mar; 39(3):1505-1515. PubMed ID: 29328462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of serum- and glucocorticoid-regulated kinase 1 and its association with clinicopathological factors and the survival of patients with adenocarcinoma of the esophagogastric junction.
    Gao S; Wang D; Kong G; Li S; Wang W; Wang H; Zhou F
    Oncol Lett; 2017 May; 13(5):3572-3578. PubMed ID: 28529581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.